HomeBOLT • NASDAQ
Bolt Biotherapeutics Inc
add
$5.66
0.35%
After Hours:(1.06%)-0.060
$5.60
Closed: Jun 18, 6:06:19 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 1.22M | -76.83% |
Operating expense | 4.14M | -39.23% |
Net income | -11.04M | -2.12% |
Net profit margin | -903.44 | -340.72% |
Earnings per share | -5.80 | -3.57% |
EBITDA | -11.72M | 29.57% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 38.84M | -57.48% |
Total assets | 85.86M | -39.91% |
Total liabilities | 39.05M | 0.82% |
Total equity | 46.81M | — |
Shares outstanding | 1.92M | — |
Price to book | 0.23 | — |
Return on assets | -32.66% | — |
Return on capital | -39.35% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -11.04M | -2.12% |
Cash from operations | -13.37M | 20.21% |
Cash from investing | 14.55M | 42.61% |
Cash from financing | — | — |
Net change in cash | 1.19M | 118.11% |
Free cash flow | -9.09M | 23.94% |
Previous close
$5.64
Day range
$5.62 - $6.07
Year range
$5.20 - $15.60
Market cap
10.85M USD
Avg Volume
36.30K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Headquarters
Website
Employees
52
